Status
Conditions
About
The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia.
Primary objective:
• To investigate the prevalence of the MetS in Korean patients with schizophrenia
Secondary objectives:
• To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Loading...
Central trial contact
Yeon-Ho Joo, Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal